BPG致力于知识发现和传播
预出版
2025/7/1 0:50:40 | Browse: 17 | 下载: 0
Publication Name 世界华人消化杂志
手稿编号 40263
手稿来源省、自治区或特别行政区 湖南省
专业类型 消化外科学
手稿栏目类型 述评
文章标题 肝细胞癌免疫检查点抑制剂相关性肺炎的机制与治疗进展
手稿来源 约稿
所有作者列表 邓楷飞, 张靓, 李乐, 费书珂
基金项目及其编号
基金项目名称 基金编号
湖南省临床医疗技术创新引导项目 2021SK51701
湖南省自然科学基金-部门联合基金项目 2023JJ60354
湖南省自然科学基金-部门联合基金项目 2025JJ81025
通讯作者 费书珂, 研究生, 副教授, 副主任医师, 421001, 蒸湘区华兴街道解放大道35号, 南华大学附属第二医院肝胆胰脾外科. pretender8129@hotmail.com
关键词 肝细胞癌; 免疫检查点抑制剂相关肺炎; 免疫检查点抑制剂; 免疫相关不良事件
核心内容提要 本文重点介绍了肝细胞癌患者发生免疫检查点抑制剂相关肺炎(checkpoint inhibitor-related pneumonitis, CIP)的机制、流行病学、诊断与鉴别诊断及治疗, 分析了CIP临床管理面临的困境和未来研究方向与管理思维的转变, 为CIP的诊治提供了参考.
引文著录 邓楷飞, 张靓, 李乐, 费书珂. 肝细胞癌免疫检查点抑制剂相关性肺炎的机制与治疗进展. 世界华人消化杂志 2025
Received
2025-04-17 16:03
Peer-Review Started
2025-04-18 07:18
To Make the First Decision
Return for Revision
2025-05-23 01:47
修回稿
2025-06-06 15:35
Second Decision
2025-06-30 00:45
期刊总编辑接受
公司总编辑接受
2025-07-01 00:50
预出版
2025-07-01 00:50
缴纳版面费
Edit the Manuscript by Language Editor
排版
ISSN 1009-3079 (print) and 2219-2859 (online)
开放获取 This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
版权 ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
网址 http://www.wjgnet.com
Assistant Editor 吴云晓健
Science Editor 刘继红
评议人编号 03656599, 03748497, 00070806, 03656526, and 03737262
Editorial Director
Journal Chief Editor
Company Chief Editor 闫佳萍
Language Editor
Production Editor
Responsible Production Editor
Responsible Science Editor
Proofing Editorial Director Jin-Lei Wang
Proofing Editor-in-Chief Lian-Sheng Ma